ClinicalTrialsFinder

Type 2 Diabetic Patients Clinical Trials in Harbin, Heilongjiang

1 recruitingHarbin, Heilongjiang, China

Showing 1–1 of 1 trials

Recruiting
Not Applicable

Comparing the Efficacy and Safety Between Continuous Subcutaneous Beinaglutide and CSII for Newly Diagnosed T2DM Patients

T2DMT2DM (Type 2 Diabetes Mellitus)Type 2 Diabetic Patients
Beijing Hospital115 enrolled16 locationsNCT03987308